TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 33249593

Group type: EXPERIMENTAL
Intervention: high-dose rhIGF‐1/rhIGFBP‐3 (60 mg/day)
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: low-dose rhIGF‐1/rhIGFBP‐3 (30 mg/day)
Number of subjects: 56
Study: 35665824

Group type: EXPERIMENTAL
Intervention: 3D visualization
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: 2D visualization
Number of subjects: 47

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 47
Study: 33392696

Group type: EXPERIMENTAL
Intervention: Dual-prefrontal transcranial direct current stimulation (tDCS) applied to both the right inferior frontal gyrus (IFG) and dorsolateral prefrontal cortex (DLPFC) with 9 cm2 electrodes, using anodal or cathodal stimulation over the IFG and opposite polarity over the DLPFC.
Number of subjects: 45

Group type: COMPARATOR
Intervention: Sham tDCS stimulation, which involved short stimulation at the start, middle, and end of the supposed 20-minute stimulation period.
Number of subjects: 45
Study: 32740188

Group type: EXPERIMENTAL
Intervention: Nurse-implemented goal-directed sedation strategy (cardiac-RESTORE)
Number of subjects: 1243
Study: 35462371

Group type: EXPERIMENTAL
Intervention: Sodium zirconium cyclosilicate (SZC) 10 g once daily during the maintenance phase
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 33888245

Group type: EXPERIMENTAL
Intervention: PARADIGM-HF
Number of subjects: 1038

Group type: EXPERIMENTAL
Intervention: PARAGON-HF
Number of subjects: 1038
Study: 36043350

Group type: EXPERIMENTAL
Intervention: Fluoxetine 10 mg once daily for 12 weeks
Number of subjects: 110

Group type: COMPARATOR
Intervention: Placebo for 12 weeks
Number of subjects: 110
Study: 35616507

Group type: EXPERIMENTAL
Intervention: DFT015 intraocular lens (AcrySof IQ Vivity Extended Vision)
Number of subjects: 218

Group type: COMPARATOR
Intervention: SN60WF aspheric monofocal control IOL (AcrySof IQ model SN60WF)
Number of subjects: 218
Study: 33020099

Group type: EXPERIMENTAL
Intervention: Targeted case finding
Number of subjects: 1621

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 1621

Group type: EXPERIMENTAL
Intervention: Patients added to a COPD register
Number of subjects: 1621
Study: 35778882

Group type: EXPERIMENTAL
Intervention: Essence containing royal jelly extract
Number of subjects: 35

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 35
Study: 32632763

Group type: COMPARATOR
Intervention: Face-to-face treatment (10 sessions, 60 minutes each)
Number of subjects: 281

Group type: EXPERIMENTAL
Intervention: Low-intensity treatment (information delivered in printed or electronic format, supported by up to four telephone sessions)
Number of subjects: 281

Group type: COMPARATOR
Intervention: Face-to-face treatment
Number of subjects: 281

Group type: EXPERIMENTAL
Intervention: Low-intensity delivery
Number of subjects: 281
Study: 35450913

Group type: COMPARATOR
Intervention: Complex continuum of care intervention delivered by community health workers, including health literacy material, multimicronutrient supplement, health services, feedback, and behaviour change support sessions.
Number of subjects: 6800
Study: 32962539

Group type: EXPERIMENTAL
Intervention: Cognitive Task (CT) - Stroop task
Number of subjects: 9

Group type: COMPARATOR
Intervention: Control Condition (CON) - viewing a documentary exhibition
Number of subjects: 9
Study: 35062988

Group type: EXPERIMENTAL
Intervention: Naoxintong capsules (NXT)
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: Buyang Huanwu granules (BYHW)
Number of subjects: 128

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 128
Study: 32007169

Group type: EXPERIMENTAL
Intervention: Pharmacological cardioversion followed by electrical cardioversion (drug-shock)
Number of subjects: 396

Group type: COMPARATOR
Intervention: Electrical cardioversion alone (shock-only)
Number of subjects: 396

Group type: EXPERIMENTAL
Intervention: Drug infusion only (part of drug-shock group)
Number of subjects: 396

Group type: EXPERIMENTAL
Intervention: Anterolateral pad positions
Number of subjects: 396

Group type: COMPARATOR
Intervention: Anteroposterior pad positions
Number of subjects: 396
Study: 35306247

Group type: EXPERIMENTAL
Intervention: 5inD mobile application
Number of subjects: 57
Study: 32571429

Group type: EXPERIMENTAL
Intervention: Early ART initiation (≤14 days after PCP diagnosis)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Deferred ART initiation (>14 days after PCP diagnosis)
Number of subjects: 200
Study: 34986285

Group type: EXPERIMENTAL
Intervention: Relatlimab and Nivolumab
Number of subjects: 0

Group type: COMPARATOR
Intervention: Nivolumab
Number of subjects: 0
Study: 34587963

Group type: EXPERIMENTAL
Intervention: Orthobox application (case group)
Number of subjects: 120

Group type: COMPARATOR
Intervention: No access to Orthobox application (control group)
Number of subjects: 120
Study: 32648835

Group type: EXPERIMENTAL
Intervention: Detailed preoperative patient education and counselling about the mode of anaesthesia, extubation process, and expected response at extubation.
Number of subjects: 100

Group type: COMPARATOR
Intervention: Routine counselling (control group).
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Detailed preoperative patient education and counselling.
Number of subjects: 100
Study: 33494832

Group type: EXPERIMENTAL
Intervention: active tDCS (0.8 A/m2)
Number of subjects: 12

Group type: COMPARATOR
Intervention: sham tDCS
Number of subjects: 12
Study: 34896904

Group type: EXPERIMENTAL
Intervention: Probiotics (three capsules, twice/day)
Number of subjects: 159

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 159
Study: 33055456

Group type: EXPERIMENTAL
Intervention: Irregular protrusion
Number of subjects: 186

Group type: EXPERIMENTAL
Intervention: Smooth protrusion
Number of subjects: 186

Group type: EXPERIMENTAL
Intervention: Disrupted fibrous tissue protrusion
Number of subjects: 186
Study: 35891492

Group type: EXPERIMENTAL
Intervention: Urodynamic evaluation
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Ultrasonographic evaluation
Number of subjects: 40

Group type: COMPARATOR
Intervention: Cystographic evaluation
Number of subjects: 40

Group type: COMPARATOR
Intervention: Scintigraphic evaluation
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Postvoid residual volume assessment
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Assessment of febrile urinary tract infection
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Assessment of intestinal constipation
Number of subjects: 40
Study: 34496941

Group type: COMPARATOR
Intervention: Anterior cervical decompression and fusion (ACDF)
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Posterior foraminotomy (PF)
Number of subjects: 110
Study: 32643886

Group type: EXPERIMENTAL
Intervention: Thunder-fire moxibustion combined with electroacupuncture
Number of subjects: 72

Group type: COMPARATOR
Intervention: Diclofenac sodium double-release enteric-coated capsules and Fugui Gutong capsules
Number of subjects: 72
Study: 35246620

Group type: EXPERIMENTAL
Intervention: Anodal tDCS with upper extremity rehabilitation
Number of subjects: 44

Group type: COMPARATOR
Intervention: Sham tDCS with upper extremity rehabilitation
Number of subjects: 44
Study: 32487567

Group type: EXPERIMENTAL
Intervention: Osimertinib
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 35537121

Group type: EXPERIMENTAL
Intervention: Active HD-tDCS
Number of subjects: 28

Group type: COMPARATOR
Intervention: Sham HD-tDCS
Number of subjects: 28
Study: 32450720

Group type: EXPERIMENTAL
Intervention: Viscotrabeculotomy
Number of subjects: 92

Group type: COMPARATOR
Intervention: Conventional trabeculotomy
Number of subjects: 92
Study: 33010112

Group type: EXPERIMENTAL
Intervention: Axitinib (5 mg orally twice daily)
Number of subjects: 19
Study: 32488238

Group type: EXPERIMENTAL
Intervention: TrP dry needling
Number of subjects: 19

Group type: COMPARATOR
Intervention: non-TrP dry needling
Number of subjects: 19
Study: 35263862

Group type: EXPERIMENTAL
Intervention: Goal-Directed Fluid Therapy (GDFT)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (routine hemodynamic monitoring)
Number of subjects: 40
Study: 33536156

Group type: COMPARATOR
Intervention: Live bedside music performed by professional musicians, once a day for six or seven consecutive days
Number of subjects: 0
Study: 32684500

Group type: EXPERIMENTAL
Intervention: Decision-aid (DA) tool
Number of subjects: 3547

Group type: COMPARATOR
Intervention: Control group (no DA tool)
Number of subjects: 3547
Study: 36049050

Group type: EXPERIMENTAL
Intervention: Gut microbiome L-tryptophan biosynthesis during acute COVID-19
Number of subjects: 52

Group type: COMPARATOR
Intervention: Plasma 5-HT concentration at the time of COVID-19
Number of subjects: 52
Study: 33814432

Group type: EXPERIMENTAL
Intervention: Global cognition and cognitive domain function
Number of subjects: 309

Group type: EXPERIMENTAL
Intervention: Visuospatial ability and EF (verbal fluency)
Number of subjects: 309
Study: 36167574

Group type: EXPERIMENTAL
Intervention: Intravenous anesthesia with propofol
Number of subjects: 344

Group type: COMPARATOR
Intervention: Inhalation anesthesia with sevoflurane
Number of subjects: 344
Study: 32712226

Group type: EXPERIMENTAL
Intervention: BMI genetic risk scores (hpGRS)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: BMI genetic risk scores (sGRS)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: BMI and hpGRS
Number of subjects: 0
Study: 32097899

Group type: EXPERIMENTAL
Intervention: Machine learning-based tumor tracking system
Number of subjects: 8
Study: 35150590

Group type: COMPARATOR
Intervention: 0.25% sodium hypochlorite (positive control)
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: 0.15% Triclosan
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Denture disinfecting tablets
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Denture disinfecting tablets plus palatine mucosa brushing solution
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: All interventions
Number of subjects: 108
Study: 32448992

Group type: EXPERIMENTAL
Intervention: Wheat soya blend plus (WSBP) provided during pregnancy and lactation (5 kg/month, 165 g/day)
Number of subjects: 2030

Group type: EXPERIMENTAL
Intervention: Wheat soya blend plus (WSBP)
Number of subjects: 2030
Study: 32827193

Group type: EXPERIMENTAL
Intervention: Combination therapy (topical corticosteroids + antibiotics)
Number of subjects: 59

Group type: COMPARATOR
Intervention: Topical corticosteroids treatment
Number of subjects: 59
Study: 35090987

Group type: EXPERIMENTAL
Intervention: Carvedilol
Number of subjects: 87

Group type: COMPARATOR
Intervention: Bisoprolol
Number of subjects: 87
Study: 34369693

Group type: EXPERIMENTAL
Intervention: Huayu Tongluo moxibustion combined with acupuncture at Jing‐well points on the differentiated meridians and routine acupuncture
Number of subjects: 60

Group type: COMPARATOR
Intervention: Donepezil, 5 mg once a day for 4 weeks
Number of subjects: 60
Study: 35191202

Group type: EXPERIMENTAL
Intervention: Aerobic training
Number of subjects: 248

Group type: EXPERIMENTAL
Intervention: Resistance training
Number of subjects: 248

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 248
Study: 33907785

Group type: EXPERIMENTAL
Intervention: Twin‐block appliance combined with straight wire appliance
Number of subjects: 60

Group type: COMPARATOR
Intervention: Straight wire appliance
Number of subjects: 60
Study: 33907888

Group type: EXPERIMENTAL
Intervention: Kahook Dual Blade ab interno trabeculectomy combined with phacoemulsification
Number of subjects: 33

Group type: COMPARATOR
Intervention: Cataract surgery alone
Number of subjects: 33
Study: 32592571

Group type: EXPERIMENTAL
Intervention: Shock wave therapy (SVT) + transcerebral magnetotherapy
Number of subjects: 40

Group type: COMPARATOR
Intervention: Shock wave therapy (SVT)
Number of subjects: 40
Study: 35320317

Group type: EXPERIMENTAL
Intervention: Severe pneumonia (cases)
Number of subjects: 2597

Group type: COMPARATOR
Intervention: Pneumonia (controls)
Number of subjects: 2597
Study: 32914509

Group type: EXPERIMENTAL
Intervention: Bioglass-containing desensitising toothpaste
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Gluma desensitiser
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Coronal pulpotomy using Biodentine
Number of subjects: 61
Study: 34976102

Group type: EXPERIMENTAL
Intervention: Lateral Direct Anterior Approach (L-DAA)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Traditional Posterolateral Approach (PLA)
Number of subjects: 24
Study: 33067484

Group type: EXPERIMENTAL
Intervention: Machine-learning classifiers using multiparametric MRI sequences (axial T1WI, T2WI, CE-T1WI, ADC maps)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Combination of all MRI sequences excluding ADC map
Number of subjects: 60
Study: 33140215

Group type: EXPERIMENTAL
Intervention: L-DOPA
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: amisulpride
Number of subjects: 45

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 45
Study: 32545250

Group type: EXPERIMENTAL
Intervention: Oral vitamin D supplementation of 400 IU/day
Number of subjects: 195

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 195
Study: 35472660

Group type: EXPERIMENTAL
Intervention: Inspiratory muscle strength training (IMST) at 50% of maximal inspiratory pressure (MIP) for 7 days/8 weeks
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Inspiratory muscle endurance training (IMET) at 30% of MIP for 7 days/8 weeks
Number of subjects: 32

Group type: COMPARATOR
Intervention: Control group (not explicitly defined, but implied as the comparison between IMST and IMET)
Number of subjects: 32
Study: 33848836

Group type: EXPERIMENTAL
Intervention: Aspartate transaminase and/or alanine transaminase ratio (DRR)
Number of subjects: 183

Group type: EXPERIMENTAL
Intervention: Receiver operating characteristic (ROC) curve analysis of DRR
Number of subjects: 183

Group type: EXPERIMENTAL
Intervention: Stratification by optimal DRR cutoff value of 1.29
Number of subjects: 183
Study: 36243103

Group type: COMPARATOR
Intervention: Control group using high-definition (HD) white-light endoscopy
Number of subjects: 25304

Group type: COMPARATOR
Intervention: Control group with primary colonoscopy screening (12 RCTs)
Number of subjects: 25304

Group type: COMPARATOR
Intervention: Control group with FIT as an indication for colonoscopy
Number of subjects: 25304

Group type: COMPARATOR
Intervention: Control group with age as a factor
Number of subjects: 25304

Group type: COMPARATOR
Intervention: Control group with sex as a factor
Number of subjects: 25304

Group type: COMPARATOR
Intervention: Control group with withdrawal time as a factor
Number of subjects: 25304

Group type: COMPARATOR
Intervention: Control group with methodological factors
Number of subjects: 25304
Study: 33385694

Group type: EXPERIMENTAL
Intervention: DOMS (eccentric exercise)
Number of subjects: 53

Group type: COMPARATOR
Intervention: Sham condition (concentric exercise)
Number of subjects: 53
Study: 32671536

Group type: COMPARATOR
Intervention: Long tube (LT)
Number of subjects: 223

Group type: EXPERIMENTAL
Intervention: Nasogastric tube with Gastrografin (NGT-G)
Number of subjects: 223

Group type: COMPARATOR
Intervention: Nasogastric tube alone (NGT)
Number of subjects: 223
Study: 35843782

Group type: EXPERIMENTAL
Intervention: Therapeutic education intervention using medical imaging visualization with the software 'Stone of Orthanc'
Number of subjects: 49

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Therapeutic education intervention
Number of subjects: 49

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 49
Study: 32871100

Group type: EXPERIMENTAL
Intervention: Mavacamten
Number of subjects: 251

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 251
Study: 36264607

Group type: EXPERIMENTAL
Intervention: Web-based stress management intervention (SMI)
Number of subjects: 262

Group type: COMPARATOR
Intervention: Waitlist control (WLC)
Number of subjects: 262
Study: 35399847

Group type: EXPERIMENTAL
Intervention: Four-in-one optimized emergency nursing procedure
Number of subjects: 78

Group type: COMPARATOR
Intervention: Routine emergency care (Control)
Number of subjects: 78
Study: 34024137

Group type: EXPERIMENTAL
Intervention: Intervention group I (prompting)
Number of subjects: 141

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 141

Group type: EXPERIMENTAL
Intervention: Intervention group II (not specified)
Number of subjects: 141
Study: 32827953

Group type: EXPERIMENTAL
Intervention: Strap intermuscular approach
Number of subjects: 104

Group type: COMPARATOR
Intervention: Traditional approach
Number of subjects: 104
Study: 34311004

Group type: EXPERIMENTAL
Intervention: Target volume delineation informed by 1F-FDG PET and CT plus elective nodal irradiation (arm A)
Number of subjects: 205

Group type: COMPARATOR
Intervention: Target volumes informed by PET alone (arm B)
Number of subjects: 205
Study: 32445474

Group type: EXPERIMENTAL
Intervention: Intrapartum oral azithromycin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 0
Study: 32512963

Group type: EXPERIMENTAL
Intervention: AHH group (6% hydroxyethyl starch 130/0.4 at a rate of 20 ml/min after anesthesia induction)
Number of subjects: 80

Group type: COMPARATOR
Intervention: C group (no AHH)
Number of subjects: 80
Study: 35988587

Group type: EXPERIMENTAL
Intervention: CYP2C19 genotype-guided antithrombotic treatment (clopidogrel 75 mg for normal metabolizers, clopidogrel 150 mg for intermediate metabolizers, acetylsalicylic acid 80 mg plus rivaroxaban 2.5 mg for poor metabolizers)
Number of subjects: 2276

Group type: COMPARATOR
Intervention: Clopidogrel 75 mg once daily (control group)
Number of subjects: 2276

Group type: EXPERIMENTAL
Intervention: CYP2C19 genotype-guided antithrombotic treatment
Number of subjects: 2276
Study: 34157755

Group type: EXPERIMENTAL
Intervention: Cannabis use for treating IBD
Number of subjects: 417

Group type: EXPERIMENTAL
Intervention: Cannabis use for recreational purposes
Number of subjects: 417

Group type: COMPARATOR
Intervention: Non-users of cannabis
Number of subjects: 417
Study: 36281107

Group type: EXPERIMENTAL
Intervention: ILIB (intravascular laser irradiation of blood) with 2 sessions of 20 minutes for 12 weeks
Number of subjects: 45

Group type: COMPARATOR
Intervention: Placebo laser application with 2 sessions of 20 minutes for 12 weeks
Number of subjects: 45

Group type: COMPARATOR
Intervention: Control group with no treatment
Number of subjects: 45
Study: 32807627

Group type: EXPERIMENTAL
Intervention: Initial attitudes toward legalization of AR‐EAS
Number of subjects: 1711

Group type: EXPERIMENTAL
Intervention: Viewing one of six randomly assigned scenarios depicting an ethical or practical issue in AR‐EAS
Number of subjects: 1711

Group type: EXPERIMENTAL
Intervention: Support for AR‐EAS legalization after reading specific scenarios
Number of subjects: 1711
Study: 35379380

Group type: EXPERIMENTAL
Intervention: Prophylactic amoxicillin‐clavulanic acid (0.375 mg/mL) for 14 days
Number of subjects: 2

Group type: COMPARATOR
Intervention: Untreated drinking water (Control)
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Combination of C. bovis inoculation and oral antibiotics (Cb+Abx+)
Number of subjects: 2
Study: 32868370

Group type: EXPERIMENTAL
Intervention: Immunity
Number of subjects: 1204

Group type: COMPARATOR
Intervention: Antibody
Number of subjects: 1204

Group type: EXPERIMENTAL
Intervention: Passport
Number of subjects: 1204

Group type: EXPERIMENTAL
Intervention: Certificate
Number of subjects: 1204

Group type: EXPERIMENTAL
Intervention: Perceiving no risk of infection
Number of subjects: 1204
Study: 34431001

Group type: EXPERIMENTAL
Intervention: SCTG + EDTA
Number of subjects: 20

Group type: COMPARATOR
Intervention: SCTG
Number of subjects: 20
Study: 34050362

Group type: EXPERIMENTAL
Intervention: Endometrial scratch (ES) procedure
Number of subjects: 1048

Group type: COMPARATOR
Intervention: TAU (no endometrial scratch)
Number of subjects: 1048
Study: 32199016

Group type: EXPERIMENTAL
Intervention: Intermittent hypoxic exposure (IHE) combined with sports training (n=6)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control group (sports training only, n=6)
Number of subjects: 12
Study: 36045948

Group type: EXPERIMENTAL
Intervention: Bridge combined internal fixation system (BCFS)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Plate fixation (Control)
Number of subjects: 100
Study: 34187478

Group type: EXPERIMENTAL
Intervention: Genetically mimicking statins
Number of subjects: 1701

Group type: EXPERIMENTAL
Intervention: Genetically mimicking PCSK9 inhibitors or ezetimibe
Number of subjects: 1701

Group type: EXPERIMENTAL
Intervention: Genetically higher LDL-c
Number of subjects: 1701
Study: 33548944

Group type: EXPERIMENTAL
Intervention: Absorbable hemostatic powder
Number of subjects: 21

Group type: COMPARATOR
Intervention: Nasopore
Number of subjects: 21
Study: 32150272

Group type: EXPERIMENTAL
Intervention: Vertebroplasty
Number of subjects: 0
Study: 32534948

Group type: EXPERIMENTAL
Intervention: Mediterranean-style dietary pattern (MED-diet)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 23
Study: 35298280

Group type: COMPARATOR
Intervention: Three scans (6, 18, and 36 months)
Number of subjects: 669

Group type: EXPERIMENTAL
Intervention: Seven scans (6, 12, 18, 24, 36, 48, and 60 months)
Number of subjects: 669

Group type: EXPERIMENTAL
Intervention: MRI (three scans)
Number of subjects: 669

Group type: COMPARATOR
Intervention: CT (seven scans)
Number of subjects: 669

Group type: EXPERIMENTAL
Intervention: Overall survival
Number of subjects: 669

Group type: EXPERIMENTAL
Intervention: Noninferiority of MRI versus CT
Number of subjects: 669
Study: 34482319

Group type: EXPERIMENTAL
Intervention: Intravenous vitamin C and thiamine for 48 hours
Number of subjects: 97

Group type: COMPARATOR
Intervention: Control group (placebo)
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: Both treatment and control groups
Number of subjects: 97
Study: 33191629

Group type: EXPERIMENTAL
Intervention: Continuous artificial gravity training on a short-arm centrifuge (30 min/day)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Intermittent centrifugation (6 x 5 min/day)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Bed rest (all groups)
Number of subjects: 24
Study: 36189794

Group type: EXPERIMENTAL
Intervention: MC4R agonism
Number of subjects: 31

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 31
Study: 33676197

Group type: EXPERIMENTAL
Intervention: Eculizumab (1200 mg/2 weeks)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Eculizumab
Number of subjects: 52